fifty infertile women with oligomenorrhea , anovulation , or luteal phase defects were selected for a combined therapy consisting of a gonadotropin-releasing hormone analog ( buserelin hoechst ag , frankfurt/main , frg ) and human menopausal gonadotropin/human chorionic gonadotropin ( hmg/hcg ) .
C0021361
infertile women
C0018062
human